A. Kaplan

Publications489
h-index82
Citations23,893
Highly Influential Citations552
Claim Author Page
Author pages are created from data sourced from our academic publisher partnerships and public sources.

Recommended Authors

  • M. Maurer
  • 763 Publications • 26,551 Citations
  • M. Cicardi
  • 366 Publications • 14,409 Citations
  • M. Metz
  • 260 Publications • 12,681 Citations
  • K. Austen
  • 1,002 Publications • 64,746 Citations
  • Publications
  • Influence
The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update.
TLDR
This guideline covers the definition and classification of urticaria, taking into account the recent progress in identifying its causes, eliciting factors and pathomechanisms, and outlines evidence-based diagnostic and therapeutic approaches for the different subtypes ofUrticaria. Expand
The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria
TLDR
This guideline covers the definition and classification of urticaria, taking into account the recent progress in identifying its causes, eliciting factors and pathomechanisms, and outlines evidence‐based diagnostic and therapeutic approaches for the different subtypes ofUrticaria. Expand
Unmet clinical needs in chronic spontaneous urticaria. A GA2LEN task force report 1
TLDR
A GA2LEN task force report concluded that chronic spontaneous urticaria is a “hidden epidemic” that needs to be addressed to address the unmet clinical needs of patients. Expand
The EAACI/GA 2 LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update
TLDR
This guideline covers the definition and classification of urticaria, taking into account the recent progress in identifying its causes, eliciting factors and pathomecha. Expand
Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria.
TLDR
Omalizumab diminished clinical symptoms and signs of chronic idiopathic urticaria in patients who had remained symptomatic despite the use of approved doses of H-antihistamine therapy (licensed doses). Expand
Symposium on the definition and management of anaphylaxis: summary report.
TLDR
This dissertation aims to provide a history of medical marijuana use in the United States and Canada over a 40-year period from 1989 to 2002, with a focus on the period up to and including the year ending in 2002. Expand
Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy.
TLDR
Omalizumab was well tolerated and reduced the signs and symptoms of CIU/CSU in patients who remained symptomatic despite the use of H₁-antihistamines, leukotriene receptor antagonists, or both. Expand
Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group
TLDR
Four types of acquired and three types of hereditary angioedema were identified as separate forms from the analysis of the literature and were presented in detail at the meeting. Expand
Pathways for bradykinin formation and inflammatory disease.
TLDR
The role for bradykinin in allergic rhinitis, asthma, and anaphylaxis is to contribute to tissue hyperresponsiveness, local inflammation, and hypotension. Expand
Chronic urticaria: pathogenesis and treatment.
  • A. Kaplan
  • Medicine
  • The Journal of allergy and clinical immunology
  • 1 September 2004
TLDR
Suggested therapy for patients with severe disease involves the use of high-dose hydroxyzine or diphenhydramine when nonsedating antihistamines are ineffective, supplemented by H-2 antagonists and leukotriene antagonists. Expand
...
1
2
3
4
5
...